Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313381804> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4313381804 endingPage "176.6" @default.
- W4313381804 startingPage "176.6" @default.
- W4313381804 abstract "Abstract The use of chronic immunosuppression is a major hurdle for clinical islet transplantation as a curative modality for the treatment of type 1 diabetes. T effector cells (Teffs) are a main culprit of allograft rejection, and their pathogenic response is kept in check by CD4+CD25+FoxP3+ T regulatory cells (Tregs). The PD-1/PD-L1 immune checkpoint pathway plays an important role in the Teff/Treg balance with demonstrated clinical efficacy in cancer immunotherapy. This study was designed to assess the immunoregulatory function of PD-L1 in preventing allogeneic islet graft rejection. A chimeric protein (SA-PD-L1) containing the extracellular portion of PD-L1 fused to a modified form of core streptavidin was generated. SA-PD-L1 protein was expressed in insect cells and purified. The protein was functional as it enhanced TGF-beta-induced conversion of Teffs into Tregs and suppressed the proliferation of Teffs in response to alloantigens. Importantly, SA-PD-L1 was transiently displayed on the surface of biotinylated islets, and such engineered islets survived for over 100 days in allogeneic recipients treated with a short course (15 days) of low dose rapamycin. In marked contrast, unmodified islets under the same rapamycin regimen were rejected within 20 days. SA-PD-L1-engineered islets without rapamycin, although showing prolonged survival, were eventually rejected within 40 days. These results provide strong proof-of-efficacy and feasibility for the use of SA-PD-L1 protein as an immunomodulator to promote allogeneic islet graft survival in the absence of continued immunosuppression." @default.
- W4313381804 created "2023-01-06" @default.
- W4313381804 creator A5004759082 @default.
- W4313381804 creator A5011208920 @default.
- W4313381804 creator A5024708104 @default.
- W4313381804 creator A5026749521 @default.
- W4313381804 creator A5037198997 @default.
- W4313381804 creator A5049976699 @default.
- W4313381804 creator A5050964019 @default.
- W4313381804 creator A5065868161 @default.
- W4313381804 creator A5077060710 @default.
- W4313381804 creator A5091023729 @default.
- W4313381804 date "2018-05-01" @default.
- W4313381804 modified "2023-09-27" @default.
- W4313381804 title "PD-L1-engineered pancreatic islet grafts overcome rejection in allogeneic recipients" @default.
- W4313381804 doi "https://doi.org/10.4049/jimmunol.200.supp.176.6" @default.
- W4313381804 hasPublicationYear "2018" @default.
- W4313381804 type Work @default.
- W4313381804 citedByCount "0" @default.
- W4313381804 crossrefType "journal-article" @default.
- W4313381804 hasAuthorship W4313381804A5004759082 @default.
- W4313381804 hasAuthorship W4313381804A5011208920 @default.
- W4313381804 hasAuthorship W4313381804A5024708104 @default.
- W4313381804 hasAuthorship W4313381804A5026749521 @default.
- W4313381804 hasAuthorship W4313381804A5037198997 @default.
- W4313381804 hasAuthorship W4313381804A5049976699 @default.
- W4313381804 hasAuthorship W4313381804A5050964019 @default.
- W4313381804 hasAuthorship W4313381804A5065868161 @default.
- W4313381804 hasAuthorship W4313381804A5077060710 @default.
- W4313381804 hasAuthorship W4313381804A5091023729 @default.
- W4313381804 hasConcept C126322002 @default.
- W4313381804 hasConcept C134018914 @default.
- W4313381804 hasConcept C165220095 @default.
- W4313381804 hasConcept C203014093 @default.
- W4313381804 hasConcept C2776090121 @default.
- W4313381804 hasConcept C2777701055 @default.
- W4313381804 hasConcept C2777702733 @default.
- W4313381804 hasConcept C2779727006 @default.
- W4313381804 hasConcept C2780252810 @default.
- W4313381804 hasConcept C2911091166 @default.
- W4313381804 hasConcept C502942594 @default.
- W4313381804 hasConcept C555293320 @default.
- W4313381804 hasConcept C71924100 @default.
- W4313381804 hasConcept C79484868 @default.
- W4313381804 hasConcept C8891405 @default.
- W4313381804 hasConceptScore W4313381804C126322002 @default.
- W4313381804 hasConceptScore W4313381804C134018914 @default.
- W4313381804 hasConceptScore W4313381804C165220095 @default.
- W4313381804 hasConceptScore W4313381804C203014093 @default.
- W4313381804 hasConceptScore W4313381804C2776090121 @default.
- W4313381804 hasConceptScore W4313381804C2777701055 @default.
- W4313381804 hasConceptScore W4313381804C2777702733 @default.
- W4313381804 hasConceptScore W4313381804C2779727006 @default.
- W4313381804 hasConceptScore W4313381804C2780252810 @default.
- W4313381804 hasConceptScore W4313381804C2911091166 @default.
- W4313381804 hasConceptScore W4313381804C502942594 @default.
- W4313381804 hasConceptScore W4313381804C555293320 @default.
- W4313381804 hasConceptScore W4313381804C71924100 @default.
- W4313381804 hasConceptScore W4313381804C79484868 @default.
- W4313381804 hasConceptScore W4313381804C8891405 @default.
- W4313381804 hasIssue "1_Supplement" @default.
- W4313381804 hasLocation W43133818041 @default.
- W4313381804 hasOpenAccess W4313381804 @default.
- W4313381804 hasPrimaryLocation W43133818041 @default.
- W4313381804 hasRelatedWork W111751319 @default.
- W4313381804 hasRelatedWork W1576052383 @default.
- W4313381804 hasRelatedWork W2011077718 @default.
- W4313381804 hasRelatedWork W2355459301 @default.
- W4313381804 hasRelatedWork W2948242186 @default.
- W4313381804 hasRelatedWork W3126427020 @default.
- W4313381804 hasRelatedWork W4281290036 @default.
- W4313381804 hasRelatedWork W4281294337 @default.
- W4313381804 hasRelatedWork W4296781885 @default.
- W4313381804 hasRelatedWork W4313381804 @default.
- W4313381804 hasVolume "200" @default.
- W4313381804 isParatext "false" @default.
- W4313381804 isRetracted "false" @default.
- W4313381804 workType "article" @default.